The LPA variants associated with PAD in our study, irrespective of smoking or diabetes status have also been associated with plasma Lp(a) levels.16,17 Mendelian randomization studies in the UKBB have also shown that one SD reduction in Lp(a) levels was associated with a 31% lower risk of PAD. Here, LPA is linked to peripheral arterial disease.